Filing Details

Accession Number:
0001144204-12-022617
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-19 10:15:53
Reporting Period:
2012-04-18
Filing Date:
2012-04-19
Accepted Time:
2012-04-19 09:15:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1114220 Keryx Biopharmaceuticals Inc KERX Pharmaceutical Preparations (2834) 134087132
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251213 Ron Bentsur C/O Keryx Biopharmaceuticals, Inc.
750 Lexington Avenue
New York NY 10022
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-18 15,300 $1.30 475,676 No 4 P Direct
Common Stock Acquisiton 2012-04-18 3,800 $1.29 479,476 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Of the 479,476 shares, 124,668 are shares of restricted stock.